| Literature DB >> 35283273 |
Zhuoqing Xu1, Han Gao1, Yuchen Zhang1, Wenqing Feng1, Yiming Miao2, Zifeng Xu1, Wenchang Li2, Fangqian Chen2, Zeping Lv2, Jianting Huo1, Wangyi Liu1, Xiaohui Shen2, Yaping Zong3, Jingkun Zhao4, Aiguo Lu5.
Abstract
CXCL5 is overexpressed in colorectal cancer (CRC) and promotes distant metastasis and angiogenesis of tumors; however, the underlying mechanism that mediates CXCL5 overexpression in CRC remains unclear. Here, we successfully extracted and identified primary mesenchymal stromal cells (MSCs) and verified the promoting effects of tumor-associated MSCs on CRC proliferation and metastasis in vivo and in vitro. We found that MSCs not only promoted the expression of CXCL5 by secreting CCL7 but also secreted TGF-β to inhibit this process. After secretion, CCL7/CCR1 activated downstream CBP/P300 to acetylate KLF5 to promote CXCL5 transcription, while TGF-β reversed the effect of KLF5 on transcription activation by regulating SMAD4. Taken together, our results indicate that MSCs in the tumor microenvironment promoted the progression and metastasis of CRC and regulated the expression of CXCL5 in CRC cells by secreting CCL7 and TGF-β. KLF5 is the key site of these processes and plays a dual role in CXCL5 regulation. MSCs and their secreted factors may serve as potential therapeutic targets in the tumor environment.Entities:
Keywords: CCL7; KLF5; TGF-β; acetylation; mesenchymal stromal cells
Mesh:
Substances:
Year: 2022 PMID: 35283273 PMCID: PMC9171262 DOI: 10.1016/j.ymthe.2022.03.005
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 12.910